Stockreport

Is There An Opportunity With Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) 49% Undervaluation? [Yahoo! Finance]

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com
PDF Current share price of US$13.17 suggests Aurinia Pharmaceuticals is potentially 49% undervalued Our fair value estimate is 121% higher than Aurinia Pharmaceuticals' a [Read more]